FDA.reportPublic FDA data

azithromycin 33.3 MG/ML Extended Release Suspension [Zmax]

RxCUI
583482
RxNorm name
azithromycin 33.3 MG/ML Extended Release Suspension [Zmax]
Display name
azithromycin 33.3 MG/ML Extended Release Suspension [Zmax]
Full name
azithromycin 33.3 MG/ML Extended Release Suspension [Zmax]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c61229e8-75cb-4776-9883-c5630bc38a32Zmax 2 GM in 60 mL Extended Release Oral Suspension [PSN] · azithromycin 33.3 MG/ML Extended Release Suspension [Zmax] [SBD] · Zmax 2 GM per 60 ML Extended Release Suspension [SY] · Zmax 33.3 MG/ML Extended Release Suspension [SY]41These highlights do not include all the information needed to use ZMAX safely and effectively. See full prescribing information for ZMAX. ZMAX (azithromycin) powder, for suspension for oral use Initial U.S. Approval: 199120110126